These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


340 related items for PubMed ID: 15885100

  • 1. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D, Zhang J, Pesesse X, Payrastre B, Dumont JE, Schurmans S, Erneux C.
    FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
    [Abstract] [Full Text] [Related]

  • 2. SHIP2 controls PtdIns(3,4,5)P(3) levels and PKB activity in response to oxidative stress.
    Zhang J, Liu Z, Rasschaert J, Blero D, Deneubourg L, Schurmans S, Erneux C, Pesesse X.
    Cell Signal; 2007 Oct; 19(10):2194-200. PubMed ID: 17643961
    [Abstract] [Full Text] [Related]

  • 3. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F, Backers K, Villeret V, Pesesse X, Erneux C.
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [Abstract] [Full Text] [Related]

  • 4. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S, Pesesse X, Bodin S, Sasaki T, Viala C, Marion E, Penninger J, Schurmans S, Erneux C, Payrastre B.
    Biochem J; 2003 Nov 15; 376(Pt 1):199-207. PubMed ID: 12885297
    [Abstract] [Full Text] [Related]

  • 5. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T, Kikuchi K, Wada T, Sato A, Hori H, Murakami S, Fukui K, Ishihara H, Aota R, Kimura I, Kobayashi M.
    Endocrinology; 2003 Sep 15; 144(9):4204-14. PubMed ID: 12933696
    [Abstract] [Full Text] [Related]

  • 6. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
    Erneux C, Edimo WE, Deneubourg L, Pirson I.
    J Cell Biochem; 2011 Sep 15; 112(9):2203-9. PubMed ID: 21503961
    [Abstract] [Full Text] [Related]

  • 7. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X, Powelka AM, Soriano NA, Czech MP, Guilherme A.
    J Biol Chem; 2005 Jun 10; 280(23):22523-9. PubMed ID: 15824124
    [Abstract] [Full Text] [Related]

  • 8. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM, Fedele CG, Davies EM, Becanovic J, Mitchell CA.
    Subcell Biochem; 2012 Jun 10; 58():215-79. PubMed ID: 22403078
    [Abstract] [Full Text] [Related]

  • 9. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S, De Schutter J, Blockmans M, Xie J, Jacobs C, Vanderwinden JM, Erneux C, Pirson I.
    J Cell Physiol; 2008 Jan 10; 214(1):260-72. PubMed ID: 17620296
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
    Pesesse X, Moreau C, Drayer AL, Woscholski R, Parker P, Erneux C.
    FEBS Lett; 1998 Oct 23; 437(3):301-3. PubMed ID: 9824312
    [Abstract] [Full Text] [Related]

  • 13. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M, Watanabe K, Sasaki J, Taya C, Takasuga S, Iizuka R, Balla T, Yamazaki M, Watanabe H, Itoh R, Kuroda S, Horie Y, Förster I, Mak TW, Yonekawa H, Penninger JM, Kanaho Y, Suzuki A, Sasaki T.
    Nat Cell Biol; 2007 Jan 23; 9(1):36-44. PubMed ID: 17173042
    [Abstract] [Full Text] [Related]

  • 14. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW, Wright KL, Burgess SJ, Astoul E, Cantrell DA, Ward SG.
    J Immunol; 2002 Nov 15; 169(10):5441-50. PubMed ID: 12421919
    [Abstract] [Full Text] [Related]

  • 15. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
    Artemenko Y, Gagnon A, Ibrahim S, Sorisky A.
    J Cell Physiol; 2007 Jun 15; 211(3):598-607. PubMed ID: 17219406
    [Abstract] [Full Text] [Related]

  • 16. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
    Blero D, De Smedt F, Pesesse X, Paternotte N, Moreau C, Payrastre B, Erneux C.
    Biochem Biophys Res Commun; 2001 Apr 06; 282(3):839-43. PubMed ID: 11401540
    [Abstract] [Full Text] [Related]

  • 17. Metabolic switching of PI3K-dependent lipid signals.
    Downes CP, Leslie NR, Batty IH, van der Kaay J.
    Biochem Soc Trans; 2007 Apr 06; 35(Pt 2):188-92. PubMed ID: 17371235
    [Abstract] [Full Text] [Related]

  • 18. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T, Dixon JE.
    J Biol Chem; 1998 May 29; 273(22):13375-8. PubMed ID: 9593664
    [Abstract] [Full Text] [Related]

  • 19. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
    Mokhtari D, Al-Amin A, Turpaev K, Li T, Idevall-Hagren O, Li J, Wuttke A, Fred RG, Ravassard P, Scharfmann R, Tengholm A, Welsh N.
    Diabetologia; 2013 Jun 29; 56(6):1327-38. PubMed ID: 23462796
    [Abstract] [Full Text] [Related]

  • 20. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W.
    Oncogene; 2002 Aug 08; 21(34):5289-300. PubMed ID: 12149650
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.